432 related articles for article (PubMed ID: 18318369)
1. FDA's device inspection lacking. Two reports point to technology, staffing as key culprits.
Rhea S
Mod Healthc; 2008 Feb; 38(5):10-1. PubMed ID: 18318369
[No Abstract] [Full Text] [Related]
2. Technology assessment of medical devices at the Center for Devices and Radiological Health.
Kessler L; Richter K
Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
[TBL] [Abstract][Full Text] [Related]
3. Missing evidence.
Hayes WS
MLO Med Lab Obs; 2008 Oct; 40(10):68. PubMed ID: 18988559
[No Abstract] [Full Text] [Related]
4. Not enough warning. GAO report finds FDA's medical device monitoring lacking.
Hensley S
Mod Healthc; 1997 Mar; 27(10):102, 104. PubMed ID: 10165267
[No Abstract] [Full Text] [Related]
5. Change, but not in dollar bills. FDA needs more than money to fix problems: Congress.
Lubell J
Mod Healthc; 2008 Feb; 38(5):10-1. PubMed ID: 18320666
[No Abstract] [Full Text] [Related]
6. FDA medical device approval: things you didn't learn in medical school or residency.
Buch B
Am J Orthop (Belle Mead NJ); 2007 Aug; 36(8):407-12. PubMed ID: 17849025
[TBL] [Abstract][Full Text] [Related]
7. The FDA's role in medical device clinical studies of human subjects.
Saviola J
J Neural Eng; 2005 Mar; 2(1):S1-4. PubMed ID: 15876645
[TBL] [Abstract][Full Text] [Related]
8. Roche's microarray tests US FDA's diagnostic policy.
Kling J
Nat Biotechnol; 2003 Sep; 21(9):959-60. PubMed ID: 12949543
[No Abstract] [Full Text] [Related]
9. The evolution of substantial equivalence in FDA's premarket review of medical devices.
Goldberger BA
Food Drug Law J; 2001; 56(3):317-37. PubMed ID: 11944642
[No Abstract] [Full Text] [Related]
10. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
[TBL] [Abstract][Full Text] [Related]
11. The limited state of technology assessment for medical devices: facing the issues.
Ramsey SD; Luce BR; Deyo R; Franklin G
Am J Manag Care; 1998 Sep; 4 Spec No():SP188-99. PubMed ID: 10185994
[TBL] [Abstract][Full Text] [Related]
12. FDA's new regulatory paradigms for in vitro diagnostic devices.
Robinowitz M; Gutman SI
Cytotherapy; 1999; 1(4):353-7. PubMed ID: 20426566
[No Abstract] [Full Text] [Related]
13. The U.S. FDA's involvement in the development and utilization of D11.40's standards on rubber consumer products.
Lin CS; Herman C
Stand News; 2003 Jul; 31(7):38-41. PubMed ID: 12882219
[No Abstract] [Full Text] [Related]
14. The FDA's humanitarian device exemption program.
Eydelman MB; Chen EA
Health Aff (Millwood); 2011 Jun; 30(6):1210-2; author reply 1212. PubMed ID: 21653975
[No Abstract] [Full Text] [Related]
15. Achieving medical device safety in an era of globalization.
Meritz JK; White TL
Food Drug Law J; 2008; 63(3):647-55. PubMed ID: 19031664
[No Abstract] [Full Text] [Related]
16. Guidance of FDA's expectations of medical device manufacturers concerning the year 2000 date problem--FDA. Notice.
Fed Regist; 1998 Jun; 63(121):34433-42. PubMed ID: 10180297
[TBL] [Abstract][Full Text] [Related]
17. You have a friend at the FDA.
Schoem SR
Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1358. PubMed ID: 14676182
[No Abstract] [Full Text] [Related]
18. Medical and dental technology assessment.
Ballard GT
Technol Health Care; 1996 Sep; 4(3):291-303. PubMed ID: 8931239
[TBL] [Abstract][Full Text] [Related]
19. The Feds do it again. The EMS community grows wary--and weary--of FDA intervention.
Nordberg M
Emerg Med Serv; 1995 Mar; 24(3):40-52. PubMed ID: 10140757
[No Abstract] [Full Text] [Related]
20. Financial disclosure by clinical investigators; correction--FDA. Final rule; correction.
Fed Regist; 1998 Jun; 63(124):35134. PubMed ID: 10180634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
